[ad_1]
WEDNESDAY, Sept. 22, 2021 (HealthDay News) — Sleeplessness. Night sweats. Anxiety. Irritability. Aches and pains.
Would smoking a little pot help women deal with these common symptoms of menopause?
A good number of middle-aged women apparently think so, because they’ve been turning to marijuana to help handle the change of life, a new study reports.
“Midlife women within the menopause transition period of their life are using cannabis, and they’re using it for symptoms that tend to overlap with menopause,” said lead researcher Katherine Babyn, a graduate student at the University of Alberta in Canada.
There’s just one drawback — little to no research has proven that pot can effectively treat menopause-related symptoms, said Dr. Stephanie Faubion, medical director of the North American Menopause Society (NAMS).
“This hasn’t been studied formally in women going through menopause, and so we don’t know what the potential benefits or risks are,” Faubion said. “That’s the danger here, is we’re using a drug that has not been studied.”
For this study, Babyn and her colleagues surveyed nearly 1,500 middle-aged women in the Canadian province of Alberta.
Two-thirds of the women said they had used pot at some time, and one-third said they’d done so within the past month.
Of the current users, 75% reported that they’d been using pot for medical purposes, even though only 23% had it medically prescribed to them.
They used pot in a number of forms, including edibles (52%), oils (47%), smoked (41%) and vaped (26%).
The products they used combined cannabidiol (CBD) and THC, which is the chemical in pot that causes intoxication. About 58% reported using CBD/THC blends, while 36% used products with high THC and 35% used products with high CBD.
The most common menopause-related issues they were trying to address with pot included:
- Trouble sleeping (74%)
- Anxiety (59%)
- Difficulty concentrating (58%)
- Irritability (55%)
- Muscle and joint aches (53%).
Across the board, women who used cannabis reported more menopause symptoms than those who didn’t use, “but we can’t establish which way that relationship goes,” Babyn said.
Faubion said the findings tell her that women who use cannabis have worse symptoms.
“Is it that they have worse symptoms that’s driving them to cannabis, or is the cannabis making their symptoms worse?” she said. “We can’t really make conclusions based on this article.”
Up to 74% of the women reported improvement in their symptoms after using cannabis, said senior researcher Nese Yuksel, a professor of pharmacy and pharmaceutical sciences at the University of Alberta.
But because it was a general question relating to all symptoms, “we can’t make any real association with it,” Yuksel said. “What we feel is that women feel they’re getting some benefit, but we can’t say that conclusively.”
Faubion, Yuksel and Babyn agreed that until more medical evidence has accrued regarding pot’s benefits, women are better off relying on tried-and-true menopause treatments.
“There is a need for future research to really investigate whether cannabis would be effective and safe for managing menopause symptoms,” Babyn said.
Faubion agreed.
“We have safe and effective therapies for menopause symptoms,” she said. “I would not be directing them to something that hasn’t been studied.”
Doctors should reach out to patients to assess their symptoms and steer them toward effective treatments, Yuksel said.
“It’s a wake-up call to say we need to have these discussions with our patients,” she said. “A lot of women do kind of fall through the cracks as far as even getting their symptoms assessed and knowing what different approaches there are for treatment.”
The study was presented Wednesday at the annual meeting of the North American Menopause Society, in Washington, D.C. Findings presented at medical meetings are considered preliminary until published in a peer-reviewed journal.
More information
Harvard Medical School has more about dealing with the symptoms of menopause.
SOURCES: Katherine Babyn, MSc student, University of Alberta, Edmonton, Canada; Stephanie Faubion, MD, medical director, North American Menopause Society, Pepper Pike, Ohio; Nese Yuksel, PharmD, professor, pharmacy and pharmaceutical sciences, University of Alberta; North American Menopause Society, annual meeting, Washington, D.C., Sept. 22-25, 2021
[ad_2]
Source link